Results 21 to 30 of about 37,671 (280)
Pharmaceuticals, 2022 The use of rocuronium/sugammadex in otorhinolaryngologic surgery improves intubation conditions and surgical rating scales. This study primarily aimed to evaluate the effect of the combination of rocuronium and sugammadex on intraoperative anesthetic ...
E. Wu +7 more
semanticscholar +1 more source
BMJ Open, 2021 Objectives Prehospital rapid sequence induction (RSI) of anaesthesia is an intervention with significant associated risk. In this study, we aimed to investigate the haemodynamic response over time of a prehospital RSI protocol of fentanyl, ketamine and ...
E. ter Avest +5 more
semanticscholar +1 more source
Medicina, 2021 Background and Objectives: Sugammadex is widely used in anesthesia to reverse rocuronium-induced neuromuscular blockade (NMB). In patients with compromised kidney function, most drugs show alteration of their pharmacokinetic profile with reduced ...
Young-Sung Kim +5 more
semanticscholar +1 more source
The effect of long-term oral dantrolene on the neuromuscular action of rocuronium: a case report [PDF]
Korean Journal of Anesthesiology, 2014 Oral dantrolene causes a dose-dependent depression of skeletal muscle contractility. A 52-year-old man treated with oral dantrolene for spasticity after spinal cord injury was scheduled to undergo irrigation and drainage of a thigh abscess under general ...
Jinwoo Jeon +4 more
doaj +1 more source
Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report
Journal of International Medical Research, 2022 Although anaphylaxis during anaesthesia is a rare event, neuromuscular blocking drugs are responsible for 62% of anaesthesia-related anaphylaxis. However, sugammadex, a modified gamma-cyclodextrin, can encapsulate rocuronium molecules and cause the rapid
Sheng-Kai Hung +4 more
doaj +1 more source
Does Sugammadex Suppress Allergic Inflammation Due to Rocuronium in Animal Model of Rat?
Allergologia et Immunopathologia, 2021 INTRODUCTION AND OBJECTIVES There are a few reports in the literature about the successful use of sugammadex in the treatment of hypersensitivity reactions caused by rocuronium; however, the pathophysiological mechanism is still unknown.
S. Yeşiltaş +4 more
semanticscholar +1 more source
Comparison of injection pain in pediatric population; original versus generic rocuronium
Saudi Journal of Anaesthesia, 2020 Background: Rocuronium-induced injection pain causes withdrawal movements. These movements may cause accidental disruption of indwelling needles. Generic rocuronium contains low-acid concentration buffer solution compared with original rocuronium.
Fumio Watanabe +2 more
doaj +1 more source
Journal of pharmacy and practice, 2021 Background: Limited data exist to support the use of rocuronium continuous infusions in the intensive care unit (ICU). Objective: To evaluate the dosing and monitoring of adult patients who received rocuronium for hypoxemic respiratory failure during the
Mohammed Aldhaeefi +5 more
semanticscholar +1 more source
Intravenous infusion of rocuronium bromide prolongs emergence from propofol anesthesia in rats.
PLoS ONE, 2021 BackgroundNeuromuscular blocking agents induce muscle paralysis via the prevention of synaptic transmission at the neuromuscular junction and may have additional effects at other sites of action. With regard to potential effects of neuromuscular blocking
Kaoru Suzuki +6 more
doaj +1 more source
Interaction of rocuronium with human liver cytochromes P450
Journal of Pharmacological Sciences, 2015 Rocuronium is a neuromuscular blocking agent acting as a competitive antagonist of acetylcholine. Results of an inhibition of eight individual liver microsomal cytochromes P450 (CYP) are presented. As the patients are routinely premedicated with diazepam,
Eva Anzenbacherova +6 more
doaj +1 more source